Literature DB >> 6387178

In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins.

D J Arora, M Houde, D M Justewicz, R Mandeville.   

Abstract

The role of the glycoproteins of influenza virus, hemagglutinin (HA), and neuraminidase (NA) in the in vitro stimulation of natural cell-mediated cytotoxicity (NCMC) or natural killer activity of human peripheral blood lymphocytes was evaluated with radiolabeled K562 cells as target cells in an overnight chromium release assay. Three different approaches were used. (i) Purified viral proteins were obtained by extraction with Nonidet P-40, separation on a sucrose gradient, and further purification by affinity chromatography. Ficoll-Hypaque-purified peripheral blood lymphocytes exposed to HA or NA individually or to a mixture of both significantly increased NCMC (32 to 50%). (ii) Treatment of HA and NA with their respective homologous antisera or F(ab')2 antibody abrogated the stimulation of NCMC by these glycoproteins. (iii) Virions treated with proteolytic enzymes resulted in viral cores lacking either HA or NA or both activities. Compared to whole virions, viral cores devoid of HA activity only induced a 50% increase in NCMC, whereas viral cores lacking HA activity and with traces of NA activity stimulated only 10% of the NCMC. These results suggest that influenza virus-induced cell-mediated cytotoxicity is largely due to its glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387178      PMCID: PMC254604     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN; D L WOERNLEY
Journal:  Arch Biochem Biophys       Date:  1960-08       Impact factor: 4.013

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Determinants of immunity to influenza infection in man.

Authors:  C W Potter; J S Oxford
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

4.  Further investigation on the fine structure of influenza virus.

Authors:  M V Nermut
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

5.  Two-step centrifugation method. A simplification of the density-gradient procedure for the purification of influenza virus.

Authors:  D J Arora; V Pavilanis; P Robert
Journal:  Can J Microbiol       Date:  1973-05       Impact factor: 2.419

6.  The structure of influenza virus. I. The polypeptides of the virion.

Authors:  I T Schulze
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

8.  Isolation of a low molecular weight sialidase (neuraminidase) from influenza virus.

Authors:  R Seto JT BRZENIEK; R Rott
Journal:  Biochim Biophys Acta       Date:  1966-02-14

9.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.

Authors:  G Trinchieri; D Santoli; R R Dee; B B Knowles
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  4 in total

1.  Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells.

Authors:  I Kurane; D Hebblewaite; F A Ennis
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

2.  Inhibition of human natural killer cell activity by influenza virions and hemagglutinin.

Authors:  Huawei Mao; Wenwei Tu; Yinping Liu; Gang Qin; Jian Zheng; Ping-Lung Chan; Kwok-Tai Lam; J S Malik Peiris; Yu-Lung Lau
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

Review 3.  Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.

Authors:  Luca T Giurgea; David M Morens; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Vaccines (Basel)       Date:  2020-07-23

4.  Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes.

Authors:  B Charley; H Laude; C La Bonnardière
Journal:  Ann Inst Pasteur Virol       Date:  2009-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.